Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress

Journal of Infectious Diseases

Volumn 194, Issue 10, 2006, Pages 1438-1446

  Awandare, Gordon A ^a,b   Goka, Bamenla ^b   Boeuf, Philippe ^c   Tetteh, John K A ^a   Kurtzhals, Jorgen A L ^d   Behr, Charlotte ^c   Akanmori, Bartholomew Dicky ^a,b  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c INSTITUT PASTEUR   (France)

^d Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

AFRICA; ANEMIA; ARTICLE; BLOOD LEVEL; BRAIN MALARIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MALARIA FALCIPARUM; MALE; METABOLIC ACIDOSIS; NONHUMAN; PARASITEMIA; PATHOGENESIS; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RISK FACTOR; SCHOOL CHILD; SYMPTOM;

EID: 33750703225     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/508547     Document Type: Article

References (38)

1. World Health Organization. World malaria report 2005. Available at: http://www.rollbackmalaria.org/wmr2005/pdf/WMReport_lr.pdf. Accessed 19 May 2006.
2. World Health Organization (WHO). Severe falciparum malaria. WHO, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000; 94(Suppl 1):S1-90.
3. Marsh K, Forster D, Waruiru C, et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995; 332:1399-404.
4. English M, Sauerwein R, Waruiru C, et al. Acidosis in severe childhood malaria. QJM 1997; 90:263-70.
5. Maitland K, Marsh K. Pathophysiology of severe malaria in children. Acta Trop 2004; 90:131-40.
6. Mockenhaupt FP, Ehrhardt S, Burkhardt I, et al. Manifestation and outcome of severe malaria in children in northern Ghana. Am J Trop Med Hyg 2004; 71:167-72.
7. Grau GE, Taylor TE, Molyneux ME, et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989; 320:1586-91.
8. Kwiatkowski D. Tumour necrosis factor, fever and fatality in falciparum malaria. Immunol Lett 1990; 25:213-6.
9. Kurtzhals JA, Adabayeri V, Goka BQ, et al. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 1998; 351:1768-72.
10. Akanmori BD, Kurtzhals JA, Goka BQ, et al. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur Cytokine Netw 2000; 11:113-8.
11. Luty AJ, Perkins DJ, Lell B, et al. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun 2000; 68:3909-15.
12. Perkins DJ, Weinberg JB, Kremsner PG. Reduced interleukin-12 and transforming growth factor-β1 in severe childhood malaria: relationship of cytokine balance with disease severity. J Infect Dis 2000; 182:988-92.
13. Othoro C, Lal AA, Nahlen B, Koech D, Orago ASS, Udhayakumar V. A low interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 1999; 179:279-82.
14. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989; 27:81-141.
15. Peyron F, Vuillez JP, Ringwald P, et al. Plasma levels of tumor necrosis factor (TNF) and neopterin during an attack of malaria. Ann Soc Belg Med Trop 1991; 71:63-6.
16. Biemba G, Gordeuk VR, Thuma PE, Mabeza GF, Weiss G. Prolonged macrophage activation and persistent anaemia in children with complicated malaria. Trop Med Int Health 1998; 3:60-5.
17. Biemba G, Gordeuk VR, Thuma P, Weiss G. Markers of inflammation in children with severe malarial anaemia. Trop Med Int Health 2000; 5:256-62.
18. Goka BQ, Kwarko H, Kurtzhals JA, et al. Complement binding to erythrocytes is associated with macrophage activation and reduced haemoglobin in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 2001; 95:545-9.
19. Clark IA, Cowden WB. The pathophysiology of falciparum malaria. Pharmacol Ther 2003; 99:221-60.
20. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994; 6:865-73.
21. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354:610-21.
22. Burgmann H, Hollenstein U, Wenisch C, Thalhammer F, Looareesuwan S, Graninger W. Serum concentrations of MIP-1α and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria. Clin Immunol Immunopathol 1995; 76:32-6.
23. Abrams ET, Brown H, Chensue SW, et al. Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression. J Immunol 2003; 170:2759-64.
24. Chaisavaneeyakorn S, Moore JM, Mirel L, et al. Levels of macrophage inflammatory protein 1α (MIP-1α) and MIP-1β in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection. Clin Diagn Lab Immunol 2003; 10:631-6.
25. Ochiel DO, Awandare GA, Keller CC, et al. Differential regulation of beta-chemokines in children with acute falciparum malaria. Infect Immun 2005; 73:4190-7.
26. Fahey TJ III, Tracey KJ, Tekamp-Olson P, et al. Macrophage inflammatory protein 1 modulates macrophage function. J Immunol 1992; 148:2764-9.
27. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994; 22:673-9.
28. Kurtzhals JA, Goka BQ, Akanmori BD, Hviid L. The importance of strict patient definition in studies of malaria pathogenesis. Trends Parasitol 2001; 17:313-4.
29. Afari EA, Appawu M, Dunyo S, Baffoe-Wilmot A, Nkrumah FK. Malaria infection, morbidity and transmission in two ecological zones southern Ghana. Afr J Health Sci 1995; 2:312-5.
30. Waruiru CM, Newton CR, Forster D, et al. Epileptic seizures and malaria in Kenyan children. Trans R Soc Trop Med Hyg 1996; 90:152-5.
31. Stevenson MM, Riley EM. Innate immunity to malaria. Nat Rev Immunol 2004; 4:169-80.
32. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin: release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160:310-6.
33. Hiekkanen T, Skogberg K, Pettila V. Evolution of plasma proinflammatory cytokines in malaria-related ARDS treated with corticosteroids. Intensive Care Med 2001; 27:1823-4.
34. Day NP, Hien TT, Schollaardt T, et al. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis 1999; 180:1288-97.
35. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 2003; 52:313-21.
36. Barak M, Gruener N. Neopterin augmentation of tumor necrosis factor production. Immunol Lett 1991; 30:101-6.
37. Grau GE, Piguet PF, Vassalli P, Lambert PH. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev 1989; 112:49-70.
38. Clark IA, Chaudhri G. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol 1988; 70:99-103.